急性冠状动脉综合征患者管理和结局的性别差异。
Sex Disparities in Management and Outcomes Among Patients With Acute Coronary Syndrome.
机构信息
Department of Global Health, Peking University School of Public Health, Beijing, China.
Institute for Global Health and Development, Peking University, Beijing, China.
出版信息
JAMA Netw Open. 2023 Oct 2;6(10):e2338707. doi: 10.1001/jamanetworkopen.2023.38707.
IMPORTANCE
Sex disparities in the management and outcomes of acute coronary syndrome (ACS) have received increasing attention.
OBJECTIVE
To evaluate the association of a quality improvement program with sex disparities among patients with ACS.
DESIGN, SETTING, AND PARTICIPANTS: The National Chest Pain Centers Program (NCPCP) is an ongoing nationwide program for the improvement of quality of care in patients with ACS in China, with CPC accreditation as a core intervention. In this longitudinal analysis of annual (January 1, 2016, to December 31, 2020) cross-sectional data of 1 095 899 patients with ACS, the association of the NCPCP with sex-related disparities in the care of these patients was evaluated using generalized linear mixed models and interaction analysis. The robustness of the results was assessed by sensitivity analyses with inverse probability of treatment weighting. Data were analyzed from September 1, 2021, to June 30, 2022.
EXPOSURE
Hospital participation in the NCPCP.
MAIN OUTCOMES AND MEASURES
Differences in treatment and outcomes between men and women with ACS. Prehospital indicators included time from onset to first medical contact (onset-FMC), time from onset to calling an emergency medical service (onset-EMS), and length of hospital stay without receiving a percutaneous coronary intervention (non-PCI). In-hospital quality indicators included non-PCI, use of statin at arrival, discharge with statin, discharge with dual antiplatelet therapy, direct PCI for ST-segment elevation myocardial infarction (STEMI), PCI for higher-risk non-ST-segment elevation ACS, time from door to catheterization activation, and time from door to balloon. Patient outcome indicators included in-hospital mortality and in-hospital new-onset heart failure.
RESULTS
Data for 1 095 899 patients with ACS (346 638 women [31.6%] and 749 261 men [68.4%]; mean [SD] age, 63.9 [12.4] years) from 989 hospitals were collected. Women had longer times for onset-FMC and onset-EMS; lower rates of PCI, statin use at arrival, and discharge with medication; longer in-hospital delays; and higher rates of in-hospital heart failure and mortality. The NCPCP was associated with less onset-FMC time, more direct PCI rate for STEMI, lower rate of in-hospital heart failure, more drug use, and fewer in-hospital delays for both men and women with ACS. Sex-related differences in the onset-FMC time (β = -0.03 [95% CI, -0.04 to -0.01), rate of direct PCI for STEMI (odds ratio, 1.11 [95% CI, 1.06-1.17]), time from hospital door to balloon (β = -1.38 [95% CI, -2.74 to -0.001]), and rate of in-hospital heart failure (odds ratio, 0.90 [95% CI, 0.86-0.94]) were significantly less after accreditation.
CONCLUSIONS AND RELEVANCE
In this longitudinal cross-sectional study of patients with ACS from hospitals participating in the NCPCP in China, sex-related disparities in management and outcomes were smaller in some aspects by regionalization between prehospital emergency and in-hospital treatment systems and standardized treatment procedures. The NCPCP should emphasize sex disparities to cardiologists; highlight compliance with clinical guidelines, particularly for female patients; and include the reduction of sex disparities as a performance appraisal indicator.
重要性
急性冠状动脉综合征(ACS)管理和结局方面的性别差异越来越受到关注。
目的
评估一项质量改进计划与 ACS 患者中性别差异的相关性。
设计、地点和参与者:全国胸痛中心项目(NCPCP)是中国一项正在进行的全国性计划,旨在改善 ACS 患者的护理质量,CPC 认证是其核心干预措施。在对 1095899 例 ACS 患者的年度(2016 年 1 月 1 日至 2020 年 12 月 31 日)横断面数据的纵向分析中,使用广义线性混合模型和交互分析评估了 NCPCP 与这些患者护理方面的性别相关差异之间的关联。通过反概率治疗加权的敏感性分析评估了结果的稳健性。数据于 2021 年 9 月 1 日至 2022 年 6 月 30 日进行分析。
暴露因素
医院参与 NCPCP。
主要结局和测量指标
ACS 患者治疗和结局的性别差异。院前指标包括从发病到首次医疗接触(发病-FMC)的时间、从发病到呼叫急救服务(发病-EMS)的时间以及未接受经皮冠状动脉介入治疗(非 PCI)的住院时间。院内质量指标包括非 PCI、到达时使用他汀类药物、出院时使用他汀类药物、出院时使用双联抗血小板治疗、ST 段抬高型心肌梗死(STEMI)的直接 PCI、高危非 ST 段抬高型 ACS 的 PCI、门到导管激活时间和门到球囊时间。患者结局指标包括住院死亡率和住院新发心力衰竭。
结果
从 989 家医院收集了 1095899 例 ACS 患者(346638 例女性[31.6%]和 749261 例男性[68.4%];平均[SD]年龄,63.9[12.4]岁)的数据。女性发病-FMC 和发病-EMS 时间较长;PCI、到达时使用他汀类药物和出院时用药的比例较低;院内延迟时间较长;心力衰竭和死亡率较高。NCPCP 与 ACS 男性和女性的发病-FMC 时间(β=-0.03[95%CI,-0.04 至-0.01])、STEMI 的直接 PCI 率(比值比,1.11[95%CI,1.06-1.17])、医院门到球囊时间(β=-1.38[95%CI,-2.74 至-0.001])和心力衰竭住院率(比值比,0.90[95%CI,0.86-0.94])显著降低有关。
结论和相关性
在这项对参与中国 NCPCP 的医院 ACS 患者进行的纵向横断面研究中,通过院前急救和院内治疗系统之间的区域化以及标准化治疗程序,在某些方面管理和结局方面的性别差异有所缩小。NCPCP 应向心脏病专家强调性别差异;强调遵守临床指南,特别是针对女性患者;并将减少性别差异作为绩效评估指标。